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Abstract
OBJECTIVE: To assess the effectiveness and safety
of Traditional Chinese Medicine (TCM) treatment of
non-acute bronchial asthma complicated by gastro-
esophageal reflux.
METHODS: We searched databases from MEDLINE,
Cochrane Library, CNKI, VIP, CBM, Wanfang Data,
and TCM Database Systems. All randomized, con-
trolled trials (RTCs) of TCM treatment of non-acute
asthma complicated by gastroesophageal reflux
were included. Data were independently collected
by two reviewers. The standards for assessing quali-
ty described in the Cochrane Handbook for System-
atic Reviews of Interventions were used to evaluate
articles. Meta-analyses were conducted using Rev-
Man 5.0.17 software. Heterogeneity was assessed,
and a corresponding effects model was used to
merge and analyze results. Indexes used to evalu-
ate curative effects were: clinical efficacy, symptom
scores, pulmonary function values, and adverse in-
cidents. Effectiveness was indicated using risk ratio
(RR) or mean difference (MD), and 95% confidence
intervals (CIs) were calculated.
RESULTS: Six RCTs were included, involving 304 pa-
tients with non-acute asthma complicated by gas-
troesophageal reflux. The treatment groups re-
ceived Chinese drugs alone or TCM combined with
standard Western medical treatment, and the con-
trol groups received standard Western medical
treatment alone. Standard Western medical treat-
ment included anti-inflammatory drugs and bron-
chodilators for asthma, and drugs to promote gas-
tric peristalsis and inhibit gastric acid production
for gastroesophageal reflux. Methodological quali-
ty was low in all six RCTs. Two RCTs showed that
clinical efficacy was higher in the treatment group
than in the control group (RR: 1.43, 95%CI: 1.10 to
1.87 vs RR: 1.51, 95% CI: 1.09 to 2.08). One RCT
showed that the asthma score was lowered more
effectively in the treatment group than in the con-
trol group (MD: -1.10, 95% CI: -2.04 to -0.16). Two
RCTs showed that the gastroesophageal reflux
score was reduced more effectively in the treat-
ment group than in the control group (RR: -3.70,
95% CI: -4.30 to 3.10 vs RR: -5.30, 95% CI: -6.32
to -4.28). One RCT showed that some pulmonary
function values were improved more effectively in
the treatment group than in the control group (P<
0.05). No differences were seen in the various index-
es between groups in the other RCTs. No adverse
reactions, dropout rates, or follow-up rates were re-
ported in any of the RCTs.
CONCLUSIONS: The clinical symptoms of
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non-acute asthma complicated by gastroesophage-
al reflux can be improved by some Chinese drugs.
Curative effects can be increased by combining the
use of TCM with Western medicine. Because of the
small quantity and low quality of research reported
to date, it is necessary to conduct further RCTs to
confirm these results. The results of this systematic
review indicate that the quality of future clinical tri-
als should be improved by including larger patient
numbers, correctly randomizing patients into study
groups, using blinding methods to measure and as-
sess outcomes, and using accepted indexes to eval-
uate curative effects.
© 2012 JTCM. All rights reserved.
Key words: TCM; Bronchial asthma; Gastroesopha-
geal reflux; Comparison of curative effects
INTRODUCTION
Both bronchial asthma and gastroesophageal reflux are
diseases commonly seen in clinical practice. Although
they are different diseases which originate from the re-
spiratory and digestive systems, respectively, they are of-
ten encountered together in clinical practice. Review of
the literature shows that this association between the
two diseases has been confirmed by many studies both
in China and internationally[1-5]. It is generally believed
that the gastric contents regurgitated during gastro-
esophageal reflux irritates or damages tissues or organs
outside the esophagus to cause extra-esophageal symp-
toms. For example, bronchial irritation or damage may
cause asthma, and may even cause such severe aggrava-
tion of asthma symptoms that they become difficult to
control[2,4,6]. An international systematic review of asth-
ma and gastroesophageal reflux based on 28 studies
from different countries found that 59.2% of asthma
patients had symptoms of gastroesophageal reflux[5].
The current medical treatment of non-acute asthma of-
ten includes long-term administration of inhaled gluco-
corticoids to reduce inflammation. Drugs to inhibit
gastric acid production and promote gastric peristalsis
are used to treat gastroesophageal reflux. Anti-reflux
medication is often used to treat patients with asthma
complicated by gastroesophageal reflux to improve asth-
ma symptoms[7]. At present, inhaled steroids are the
most effective drugs for asthma treatment. However,
long-term steroid use may cause drug dependence.
In China, TCM treatment has been widely used to
treat asthma complicated by various symptoms. TCM
considers asthma to be caused by abnormal rise of lung
Qi, and gastroesophageal reflux to be caused by abnor-
mal rise of stomach Qi. Asthma and gastroesophageal
reflux therefore have common pathogenic mechanisms,
namely the abnormal rise of Qi. TCM is characterized
by holistic principles and by diagnosis and treatment
based on overall analysis of the symptoms, signs, cause,
nature, and location of the illness. Chinese drugs are
used to treat the incoordination between the lung and
stomach and the abnormal rise of Qi, to normalize
stomach function. Selected acupoints related to the
lung, stomach and other channels, moxibustion, and
cupping are also used. The two diseases are considered
as a whole to administer individualized treatment to pa-
tients. This therapeutic approach may have some ad-
vantages compared with the treatment of a single dis-
ease in Western medicine. Clinical TCM research has
been undertaken in recent years, but there has not
been a systematic review of the results. This review
therefore aimed to evaluate the curative effects of TCM
in the treatment of non-acute asthma complicated by
gastroesophageal reflux, and to evaluate the medical evi-
dence for clinical practices.
METHODS
Inclusion Criteria
Inclusion criteria for research papers were: 1) research
type: randomized, controlled trials, regardless of blind-
ing; 2) research subjects: patients with non-acute asth-
ma complicated by gastroesophageal reflux, regardless
of race; 3) treatment and control groups: a treatment
group receiving TCM treatment combined with stan-
dard Western medical treatment and a control group re-
ceiving placebo or no treatment, or a treatment group
receiving TCM treatment combined with Western
medical treatment and a control group receiving West-
ern medical treatment alone. TCM treatment included
oral ingestion or external application of Chinese drugs,
acupuncture, moxibustion, cupping, and Tai Chi; and
4) outcome indexes: clinical efficacy, asthma symptom
scores, gastroesophageal reflux symptom scores, pulmo-
nary function values, and adverse events.
Study Retrieval Methods
Both Chinese and English language databases were
searched. CNKI, VIP, CBM, Wanfang Data, and TCM
Database Systems were searched for Chinese literature.
PubMed and the Cochrane Library (5th edition, 2011)
were searched for English literature. Both Chinese and
English databases were searched for the words "asth-
ma" and "gastroesophageal reflux" to ensure compre-
hensive and systematic searching. Databases were
searched up to June 14, 2011.
Screening of Literature and Data Extraction
The literature-screening was based on the methods de-
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scribed in the Cochrane Handbook for Systematic Re-
views of Interventions version 5.0.2. 1) The results of
databases searches were entered into literature-manage-
ment software. 2) Headlines and abstracts were re-
viewed, and obviously unrelated literature was rejected.
3) The full text of reports on potentially eligible studies
was obtained. 4) When there were multiple reports
dealing with the same trial, repeated literature was ex-
cluded. 5) Missing data were obtained by contacting
the main researchers of studies. 6) Research reports
were checked according to the designated standard for
selected studies. 7) A final decision was made on which
studies to include. Steps 1) to 5) above were undertak-
en by the first author. Steps 6) and 7) were completed
independently by two authors (Liu Zhao-lan and Li
Lanhua) and the results were compared. Differences in
results were settled through discussion or by soliciting
the opinion of a third author (Zhao Yu-hao).Data ex-
traction forms were designed according to the aims of
the review. Two authors (Shi Cheng-he and Liu Zhao-
lan) independently extracted data, comprising: 1) gen-
eral data: title, authors, journal, and publication date;
2) study characteristics: baseline patient characteristics,
and intervention measures in the treatment and con-
trol groups; 3) indexes of curative effects, and statistics
indicating effectiveness.
Evaluation of Research Quality
Included RCTs were strictly evaluated according to the
methods of evaluating risk of bias described in the Co-
chrane Handbook for Systematic Reviews of Interven-
tions version 5.0.2. The six factors evaluated were: ran-
domization, allocation concealment, blinding, incom-
plete results data, selective reporting of outcomes, and
other potential biases. Each item was categorized as ei-
ther "yes" indicating a low risk of bias, "no" indicating
a high risk of bias, or "unclear" indicating a moderate
risk of bias when inadequate information resulted in us
being unable to categorize the factor as a definite "yes"
or "no." Assessments of the risk of bias were undertak-
en independently by two authors (Liu Zhaolan and Li
Lanhua) and the results were compared. Differences in
results were settled through discussion or by soliciting
the opinion of a third author (Zhao Yuhao).
Data Analysis
Rev Man 5.1 software was used to analyze the main
outcome indexes. Relative risk (RR) was used to com-
pare discrete variables, mean difference (MD) was used
to compare continuous variables, and 95% confidence
interval (CI) was used to express outcome. If the inter-
ventions described in treatment and control groups
were not comparable, RR or MD, rather than me-
ta-analysis, was used to describe the effects of treat-
ment.
RESULTS
Included Studies
From the 576 articles initially retrieved, 30 relevant ar-
ticles were selected by reading headlines and abstracts
and excluding obviously unrelated articles. After exclu-
sion of 19 of these 30 articles due to repetition, the full
text of the remaining 11 articles was downloaded. Two
case series articles, one case report, and one RCT with
no report of the outcome index used were excluded.
Two of the remaining seven articles were merged as
they related to the same trial[12], leaving a total of six
RCTs involving 304 patients which were included in
this review[8-13]. Figure 1 shows the literature-screening
procedure. Table 1 shows the characteristics of the in-
cluded studies.
Methodological Quality of Included Studies
All the included studies randomly assigned patients in-
to groups, but did not describe their randomization, al-
location concealment, or blinding methods. All the
studies described comparisons of baseline data between
the groups, and no reports had incomplete data.
Assessment of Outcomes
All the studies divided patients into groups with either
TCM alone or Western medicine alone, or into groups
with either TCM combined with Western medicine or
Western medicine alone. Because different recipes of
Chinese drugs were used in all the studies, no me-
ta-analysis was conducted in this systematic review.
Clinical Efficacy
The clinical efficacy of treatment between groups was
compared in four of the studies[8,9,12,13]. Two studies com-
pared TCM combined with Western medicine and
Western medicine alone[8,9], and two studies compared
TCM alone and Western medicine alone[12,13]. The re-
sults of one study in each of these two groups indicated
that curative effects were better in the treatment group
than in the control group, while the results of the other
study in each group indicated that there were no differ-
ences in curative effects between the two groups.
Asthma Scores
Cumulative asthma scores (Reid method) [14] were re-
ported in two studies[10,13]. One study which compared
the Chinese drug Xuanfu Daizhe Tang combined with
standard Western medical treatment and standard
Western medical treatment alone found that the group
who received TCM had significantly better reductions
in asthma scores than the group who did not
(MD: -1.10, 95%CI: -2.04 to -0.16)[10]. The other study
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Figure 1 PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) flow-chart of study selection.
Table 1 Basic characteristics of included studies
research
name
Dai
Siguo
1999
Wang
Chengxi
2003
Bai
Xuege
2001
Chen
Lingran
2008
Sample
amount
54
48
54
72
Number of people
Treatme
nt group
18
24
28
36
Control
group
Group
1:18
Group
2:18
24
26
36
age
Treatment
group
35±15
40±15
54±8
66±11
Control
group
Group
1:
36±17;
Groups
2:
38±18
35±15
65±11
Sex
male
23
35
30
38
female
31
13
24
34
Diagnostic
standard
asthma：
guide-
book of
Chinese
medical
associa-
tion
GER: self
drafted
asthma：
guide-
book of
Chinese
medical
association
GER: un-
clear
asthma：
guide-
book of
Chinese
medical
association
GER: bar-
ium meal
or endo-
scope for
diagnosis
asthma：
guide-
book of
Chinese
medical
association
GER: un-
clear
Therapeutic
measure
Self prescribed
recipe (Huang
Lian, Wu Zhu
Yu, Dai Zhe
Shi, Qing Ban
Xia, Su Geng,
Zhi Shi,Sha
Ren, Gan Cao)
Xuanfu Dai-
zhe Tang and
Western medi-
cal routine
treatment
Self pre-
scribed recipe
(Xuan Fu
Hua, Ban Xia,
Yuan Hu, Bai
Ji, Duan Wa
Leng, Wu Zei
Gu)
Cupping, gin-
ger-separated
moxibustion,
acupoint injec-
tion and West-
ern medical
control treat-
ment
Control
measure
Group 1:
aminophy
-lline,
salbutamol
group 2:
aminophylli,
salbutamol,
ranitidine,
cisapride
Theophyl-
line sus-
tained re-
lease tablet,
β2 receptor
exciter brica-
nyl, vitamins
Resisting in-
fection, stop-
ping cough,
releasing
asthma and
domperi-
done tablet
Domperi-
done, cimeti-
dine, salme-
terol and
fluticasone
powder in-
halant
Treatment
course
6 weeks
8 weeks
10 days
8 weeks
Outcome
index
Clinically
accumu-
lated score,
effective
rate, pul-
monary
function
Clinically
accumu-
lated score,
Effective
rate
Effective
rate, clini-
cally accu-
mulated
score
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Li
Xush-
eng
2003
Wang
Caihua
2006
41
35
20
20
21
15
21~60
38.±15.4
19~56
37.8±
16.6
18
16
23
19
asthma：
guide-
book of
Chinese
medical
association
GER: Ye
Rengao
medical
standard
asthma：
guide-
book of
Chinese
medical
association
GER: for-
eign stan-
dard
Self pre-
scribed recipe
(Sha Shen,
Ban Xia, Bai
Zhu, Wu Zhu
Yu, Huang Li-
an, Zhi Shi,
Zhi Gan Cao)
and control
treatment
Self prescribed
recipe (Ban
Xia, Zhu Ru,
Huang Qin,
Zhi Shi, Wu
Zei Gu, Gan
Cao, dry Gin-
ger) and con-
trol treatment
Inhaling sur-
face hor-
mone pulmi-
cort aerosol
Inhaling sur-
face hor-
mone
budesonide
powder
5 weeks
4 weeks
Pulmo-
nary func-
tion
Effective
rate
Note: Guidebook of Chinese Medical Association, Guidebook for preventing and treating bronchial asthma issued by respiratory disease
branch of Chinese Medical Association foreign standards: Barish CF, WuWc, Castell Do. Respiratory complications of gastroesophageal
reflux. Arch lntern Med 1985, 145(10): 1882.
showed no significant difference in asthma scores be-
tween a Chinese medicine recipe and Western medi-
cine (MD: -0.10, 95%CI: -1.15 to 0.95])[13].
Gastroesophageal Reflux Scores
Cumulative gastroesophageal scores(Harper method) [15]
were reported in three studies[8,10,13]. Two of these stud-
ies compared TCM combined with Western medicine
and Western medicine alone and found significant dif-
ferences between the two groups, while the third study
compared TCM alone and Western medicine alone
and did not find any significant differences between
the two groups (Figure 3).
Pulmonary Function
Pulmonary function values were reported in two stud-
ies[11,13]. One of these studies reported forced expiratory
volume in 1 second and peak expiratory flow values be-
fore and after treatment[11]. There were significant differ-
ences in these values before and after treatment in both
the treatment and control groups, but there were no sig-
nificant difference between the groups. The other study
reported values of vital capacity, forced vital capacity,
forced expiratory volume in 1 second, peak expiratory
flow, and 20% reduction in forced expiratory volume
in 1 second values before and after treatment[13]. There
was no significant difference in any of these values be-
tween the treatment and control groups, except for a
better forced vital capacity in the treatment group than
the control group.
Adverse Reactions
No adverse reactions were reported in any of the stud-
ies.
Analysis of Chinese Drugs Studied
The six studies used TCM compound recipes which
were modifications of basic recipes for the treatment of
various syndromes. Modified Xuanfu Daizhe Tang, a
recipe in Treatise on Febrile Diseases, was used in one
of the studies, and self-produced recipes were used in
the other five studies. Analysis of the frequency of indi-
vidual medications used showed that Ban Xia (Rhi-
zoma Pinelliae) was used in five studies, Gan Cao (Ra-
dix Glycyrrhizae) in four studies, Zhi Shi (Fructus Au-
rantii Immaturus) in three studies, Huang Lian (Rhi-
zoma Coptidis), Wu Zhu Yu (Fructus Evodiae), Dai
Zhe Shi (Ochra Haematitum), Xuan fu Hua (Flos Inu-
lae), and Wu Zei Gu (Os Sepiella seu Sepiae) in two
studies, and Su Geng (Caulis Perillae), Sha Ren (Fruc-
tus Amomi), Ren Shen (Radix Ginseng), Sheng Jiang
(Rhizoma Zingiberis Recens), Da Zao (Fructus Ziziphi
Jujubae), Yuan Hu (Rhizoma Corydalis), Bai Ji (Rhi-
zoma Bletillae), Wa Leng Zi (Concha Arcae), Sha Shen
(Radix Adenophorae Strictae), Bai Zhu (Rhizoma
Atractylodis Macrocephalae), Zhu Ru (Caulis Bambu-
sae in Taeniam), Huang Qin (Radix Scutellariae), and
Gan Jiang (Rhizoma Zingiberis) in one study. The
drugs selected for treatment were mainly for the regula-
tion of Qi flow of the stomach and lung, control of
coughing, removal of phlegm, elimination of asthma,
clearing of heat, and supplementation of deficiencies.
Funnel Plot Analysis
Because of inconsistent intervention measures, great
clinical heterogeneity, and the small number of trials,
funnel plot analysis to analyze standard deviation was
not performed.
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Figure 2 Comparisons of clinical efficacy.
Figure 3 Comparisons of cumulative gastroesophageal reflux scores.
DISCUSSION
Curative Effects of TCM in Non-acute Bronchial
Asthma Complicated by Gastroesophageal Reflux
Clinical trial results show that TCM has the same ef-
fects as Western medicine on clinical efficacy, asthma
scores, gastroesophageal reflux scores, and pulmonary
function values. TCM combined with Western medi-
cine can enhance curative effects compared with West-
ern medicine alone. However, this conclusion should
be interpreted with care because of the low method-
ological quality of the studies. Inconsistent interven-
tion measures in the currently available studies make it
impossible to evaluate the curative effects of specific
recipes, and only the effects of TCM treatment as a
whole can be evaluated. TCM should therefore only be
used when the curative effects of standard Western
medical are not ideal.
Limitations
There may be some limitations to this review due to
the methods used to retrieve studies and evaluate out-
comes. Due to language restrictions, only a small num-
ber of Chinese articles were retrieved from databases.
Although we did our best to retrieve articles compre-
hensively and systematically, some studies may have
been missed. No meta-analysis of outcome data was un-
dertaken because of the inconsistent intervention mea-
sures between studies. The curative effects of TCM and
Western medicine were only compared as a whole rath-
er than comparing individual treatments, which limits
the generalizability of the conclusion.
The limitations of the included studies also limited the
quality of our review. Low methodological quality and
lack of descriptions of randomization methods and allo-
cation concealment in the six RCTs reviewed may have
biased the results. No blinding was reported in any of
the studies. In spite of the extreme difficulty of imple-
menting blinding methods in TCM clinical research, it
is feasible and necessary to use blinding during mea-
surement of outcomes. As no descriptions of blinding
methods were given, it is difficult to exclude the possi-
bility biases in the assessment of clinical efficacy, symp-
tom scores, and other outcome indexes. In addition, all
the studies were undertaken in single centers with
small patient numbers, and some studies had a very
short treatment course. All the studies lacked informa-
tion regarding follow-up and drop-out rates.
Directions for Future Clinical Research
This review of the currently available clinical research
gives indications of the necessary directions for future
clinical and scientific research.
The TCM drugs frequently used to treat non-acute
asthma complicated by gastroesophageal reflux are Ban
Xia, Gan Cao, Zhi Shi, Huang Lian, Wu Zhu Yu, Dai
Zhe Shi, Xuan Fu Hua, and Wu Zei Gu to regulate the
stomach, lower the adverse flow of Qi, regulate Qi,
warm the stomach, clear away heat, remove phlegm,
and stop acid regurgitation. Ren Shen, Bai Zhu, and
Da Zao are used to strengthen the spleen and supple-
17
JTCM |www. journaltcm. com March 15, 2012 | volume 32 | Issue 1 |
Zhao YH et al. Systematic review of RCTs of TCM for bronchial asthma with gastroesophageal reflux
ment Qi. This reflects the therapeutic principle of
mainly treating the stomach with auxiliary treatment
of the lung in this combination of diseases. According
to the basic theories underlying TCM, the spleen and
stomach are the origin of the disease. Intervention mea-
sures undertaken in current clinical studies therefore re-
flect the TCM principle that treating the origin of the
disease can also improve symptoms and enhance cura-
tive effects.
We suggest that future clinical trials should explain the
processes of calculating sample numbers, increase sam-
ple numbers, involve multiple centers if possible, give
detailed descriptions of randomization methods and al-
location concealment, use blinding when measuring
and evaluating outcomes, report trial withdrawal and
drop-out rates, and use intentional analysis. Accepted
diagnostic standards should be adopted to determine
treatment outcomes. For example, the 2002 Guidelines
for Preventing and Treating Bronchial Asthma by the
Asthma Group of the Respiratory Diseases Branch of
the Chinese Medical Association[16] should be used to
diagnose asthma, and it should be specified whether
the asthma treated is acute or non-acute. The princi-
ples and medications used in the TCM treatment of
asthma are different in the acute and non-acute stages.
The 2006 Guidelines for Recognition of Gastroesopha-
geal Reflux by the Digestive Diseases Branch of the
Chinese Medical Association should be used to diag-
nose gastroesophageal reflux[17]. Placebo or standard
Western medical treatment should be used for control
groups. Treatment courses should adhere to the West-
ern medical standard to avoid courses that are too
short. Internationally accepted standards should be
used to evaluate curative effects using pulmonary func-
tion values, quality of life indexes[18], and adverse reac-
tions. Combination of all of the above-mentioned sug-
gestions would enhance the quality of research into the
TCM treatment of asthma complicated by gastroesoph-
ageal reflux.
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